Original Research

Published on 19 Aug 2022

Ruxolitinib inhibits cytokine production by human lung macrophages without impairing phagocytic ability

in Respiratory Pharmacology

Nikola Mantov
Mathilde Zrounba
Marion Brollo
S Grassin-Delyle
Matthieu Glorion
Mélanie David
Emmanuel Naline
Philippe Devillier
Hélène Salvator

Frontiers in Pharmacology

doi 10.3389/fphar.2022.896167

2,566 views
2 citations

Original Research

Published on 19 Aug 2022

Acteoside attenuates RSV-induced lung injury by suppressing necroptosis and regulating metabolism

in Respiratory Pharmacology

Xiaoying Ling
Jie Zhou
Tianzi Jin
Weichen Xu
Xun Sun
Weifeng Li
Yali Ding
Miaomiao Liang
Chenbi Zhu
Peipei Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.870928

3,785 views
3 citations

Review

Published on 12 Aug 2022

Research progress and applications of nanobody in human infectious diseases

in Respiratory Pharmacology

Yaxian Mei
Yuanzhi Chen
Jwala P. Sivaccumar
Zhiqiang An
Ningshao Xia
Wenxin Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2022.963978

15,710 views
31 citations

Original Research

Published on 12 Aug 2022

Self-Reported Overall Adherence and Correct Inhalation Technique Discordance in Chronic Obstructive Pulmonary Disease Population

in Respiratory Pharmacology

Tereza Hendrychova
Michal Svoboda
Josef Maly
Jiri Vlcek
Eva Zimcikova
Tomas Dvorak
Jaromir Zatloukal
Eva Volakova
Marek Plutinsky
Kristian Brat

Frontiers in Pharmacology

doi 10.3389/fphar.2022.860270

2,371 views
3 citations

Original Research

Published on 11 Aug 2022

Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial

in Respiratory Pharmacology

Qinhai Ma
Ruihan Chen
Jing Zeng
Biao Lei
Feng Ye
Qihua Wu
Zhengtu Li
Yangqing Zhan
Bin Liu
Bojun Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.968182

3,663 views

Review

Published on 11 Aug 2022

Roles of exosomes and exosome-derived miRNAs in pulmonary fibrosis

in Respiratory Pharmacology

Yongfeng Yang
Hong Huang
Yi Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.928933

5,753 views
16 citations

Original Research

Published on 10 Aug 2022

Clinical Efficacy and In Vitro Drug Sensitivity Test Results of Azithromycin Combined With Other Antimicrobial Therapies in the Treatment of MDR P. aeruginosa Ventilator-Associated Pneumonia

in Respiratory Pharmacology

Yuqin Huang
Wenguo Wang
Qiang Huang
Zhengyan Wang
Zhuanzhuan Xu
Chaochao Tu
Dongli Wan
Miaobo He
Xiaoyi Yang
Huaqiang Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.944965

2,737 views
4 citations

Case Report

Published on 22 Jul 2022

Treatment of COVID-19 Pneumonia and Acute Respiratory Distress With Ramatroban, a Thromboxane A2 and Prostaglandin D2 Receptor Antagonist: A Four-Patient Case Series Report

in Respiratory Pharmacology

Martin L. Ogletree
Kate Chander Chiang
Rashmi Kulshrestha
Aditya Agarwal
Ashutosh Agarwal
Ajay Gupta

Frontiers in Pharmacology

doi 10.3389/fphar.2022.904020

3,168 views
9 citations

Original Research

Published on 22 Jul 2022

The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19

in Respiratory Pharmacology

Ping Jiang
Jingyao Ye
Menglong Jia
Xiaopeng Li
Shujun Wei
Nianhu Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.960267

3,383 views
9 citations

Review

Published on 21 Jul 2022

Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis

in Respiratory Pharmacology

Hongbo Ma
Xuyi Wu
Yi Li
Yong Xia

Frontiers in Pharmacology

doi 10.3389/fphar.2022.963054

13,754 views
40 citations

Original Research

Published on 15 Jul 2022

Photodynamic Effects of Thuja occidentalis on Lung Cancer Cells

in Respiratory Pharmacology

Ayesha Loonat
Rahul Chandran
Janice Pellow
Heidi Abrahamse

Frontiers in Pharmacology

doi 10.3389/fphar.2022.928135

5,969 views
1 citation

Original Research

Published on 15 Jul 2022

Metformin Alleviates LPS-Induced Acute Lung Injury by Regulating the SIRT1/NF-κB/NLRP3 Pathway and Inhibiting Endothelial Cell Pyroptosis

in Respiratory Pharmacology

Yunqian Zhang
Hui Zhang
Siyuan Li
Kai Huang
Lai Jiang
Yan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.801337

8,001 views
47 citations

Original Research

Published on 15 Jul 2022

Aberrant Expression of ACO1 in Vasculatures Parallels Progression of Idiopathic Pulmonary Fibrosis

in Respiratory Pharmacology

Jutaro Fukumoto
Muling Lin
Mudassir Meraj Banday
Sahebgowda Sidramagowda Patil
Sudarshan Krishnamurthy
Mason Breitzig
Ramani Soundararajan
Lakshmi Galam
Venkata Ramireddy Narala
Colleen Johns

Frontiers in Pharmacology

doi 10.3389/fphar.2022.890380

3,127 views
1 citation

Original Research

Published on 12 Jul 2022

Number 2 Feibi Recipe Ameliorates Pulmonary Fibrosis by Inducing Autophagy Through the GSK-3β/mTOR Pathway

in Respiratory Pharmacology

Haoge Liu
Qinglu Pang
Fang Cao
Zhaoheng Liu
Wan Wei
Zhipeng Li
Qi Long
Yang Jiao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.921209

2,584 views
5 citations

Original Research

Published on 08 Jul 2022

Pre-Clinical Development of a Potent Neutralizing Antibody MW3321 With Extensive SARS-CoV-2 Variants Coverage

in Respiratory Pharmacology

Wen Jiang
Zherui Zhang
Yuhe Zhu
Ben Chen
Chunying Gu
Zhiyan Liu
Xukai Zhang
Hualong Xiong
Yanan Zhang
Bin Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.926750

3,277 views

Original Research

Published on 01 Jul 2022

Relation Between Gender and Concomitant Medications With Erythropoietin-Treatment on Wound Healing in Burn Patients. Post Hoc Subgroup-Analysis of the Randomized, Placebo-Controlled Clinical Trial “EPO in Burns”

in Respiratory Pharmacology

Christina Irene Günter
Felicitas Paula Ilg
Alexander Hapfelmeier
Silvia Egert-Schwender
Wolfgang Jelkmann
Shibashish Giri
Augustinus Bader
Hans-Günter Machens
and EPO in Burns Study Group

Frontiers in Pharmacology

doi 10.3389/fphar.2022.812888

1,884 views
2 citations

Navigation group

Articles

Ruxolitinib inhibits cytokine production by human lung macrophages without impairing phagocytic ability

Acteoside attenuates RSV-induced lung injury by suppressing necroptosis and regulating metabolism

Research progress and applications of nanobody in human infectious diseases

Self-Reported Overall Adherence and Correct Inhalation Technique Discordance in Chronic Obstructive Pulmonary Disease Population

Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial

Roles of exosomes and exosome-derived miRNAs in pulmonary fibrosis

Clinical Efficacy and In Vitro Drug Sensitivity Test Results of Azithromycin Combined With Other Antimicrobial Therapies in the Treatment of MDR P. aeruginosa Ventilator-Associated Pneumonia

Treatment of COVID-19 Pneumonia and Acute Respiratory Distress With Ramatroban, a Thromboxane A2 and Prostaglandin D2 Receptor Antagonist: A Four-Patient Case Series Report

The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19

Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis

Photodynamic Effects of Thuja occidentalis on Lung Cancer Cells

Metformin Alleviates LPS-Induced Acute Lung Injury by Regulating the SIRT1/NF-κB/NLRP3 Pathway and Inhibiting Endothelial Cell Pyroptosis

Aberrant Expression of ACO1 in Vasculatures Parallels Progression of Idiopathic Pulmonary Fibrosis

Number 2 Feibi Recipe Ameliorates Pulmonary Fibrosis by Inducing Autophagy Through the GSK-3β/mTOR Pathway

Pre-Clinical Development of a Potent Neutralizing Antibody MW3321 With Extensive SARS-CoV-2 Variants Coverage

Relation Between Gender and Concomitant Medications With Erythropoietin-Treatment on Wound Healing in Burn Patients. Post Hoc Subgroup-Analysis of the Randomized, Placebo-Controlled Clinical Trial “EPO in Burns”